Catalyst Wire Dossier Catalyst Wire Dossier

Tarceva

erlotinib · Genentech
Drug timelines are a Plus or Pro feature.

311 regulatory and trial events tracked for Tarceva, covering 2007-04-27 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Oral Cavity Cancer in a Rural Midwest United States Population [Phase 2]

See pricing